For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $1.41 in the prior trading day, Neuronetics Inc (NASDAQ: STIM) closed at $1.4, down -1.06%. In other words, the price has decreased by -$1.06 from its previous closing price. On the day, 1.06 million shares were traded. STIM stock price reached its highest trading level at $1.47 during the session, while it also had its lowest trading level at $1.36.
Ratios:
Our goal is to gain a better understanding of STIM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.09 and its Current Ratio is at 2.24. In the meantime, Its Debt-to-Equity ratio is 3.32 whereas as Long-Term Debt/Eq ratio is at 3.11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’25 when Madryn Asset Management, LP sold 3,500,000 shares for $3.72 per share. The transaction valued at 13,020,000 led to the insider holds 1,142,351 shares of the business.
MADRYN HEALTH PRTS II (CAY MAS bought 2,925,554 shares of STIM for $10,883,061 on Aug 08 ’25. On Aug 08 ’25, another insider, MADRYN HEALTH PARTNERS II, LP, who serves as the 10% Owner of the company, bought 192,806 shares for $3.72 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STIM now has a Market Capitalization of 95880288 and an Enterprise Value of 162662288. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.74 while its Price-to-Book (P/B) ratio in mrq is 3.50. Its current Enterprise Value per Revenue stands at 1.252 whereas that against EBITDA is -4.755.
Stock Price History:
The Beta on a monthly basis for STIM is 0.66, which has changed by 0.052631617 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, STIM has reached a high of $5.92, while it has fallen to a 52-week low of $1.23. The 50-Day Moving Average of the stock is -32.72%, while the 200-Day Moving Average is calculated to be -58.39%.
Shares Statistics:
The stock has traded on average 1.57M shares per day over the past 3-months and 1367740 shares per day over the last 10 days, according to various share statistics. A total of 68.44M shares are outstanding, with a floating share count of 37.25M. Insiders hold about 45.60% of the company’s shares, while institutions hold 31.14% stake in the company. Shares short for STIM as of 1764288000 were 6000423 with a Short Ratio of 3.83, compared to 1761868800 on 5531067. Therefore, it implies a Short% of Shares Outstanding of 6000423 and a Short% of Float of 15.110000000000001.
Earnings Estimates
. The current market rating for Neuronetics Inc (STIM) reflects the collective analysis of 2.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.11 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.59 and -$0.61 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.47, with 2.0 analysts recommending between -$0.46 and -$0.49.
Revenue Estimates
3 analysts predict $40.66M in revenue for. The current quarter. It ranges from a high estimate of $40.99M to a low estimate of $40.3M. As of. The current estimate, Neuronetics Inc’s year-ago sales were $22.1MFor the next quarter, 3 analysts are estimating revenue of $37.22M. There is a high estimate of $38M for the next quarter, whereas the lowest estimate is $36.45M.
A total of 3 analysts have provided revenue estimates for STIM’s current fiscal year. The highest revenue estimate was $148.55M, while the lowest revenue estimate was $147.7M, resulting in an average revenue estimate of $148.08M. In the same quarter a year ago, actual revenue was $74.5MBased on 3 analysts’ estimates, the company’s revenue will be $164.15M in the next fiscal year. The high estimate is $164.65M and the low estimate is $163.8M.
